A new trial listing related to glucagon was registered on November 13, 2026. The study, titled "A Phase I Study to Evaluate the Food Effect on Ecnoglutide Tablet," is registered under identifier NCT07936058.
This is a Phase 1 trial. Its current status is listed as not yet recruiting. The study is designed to evaluate the food effect on the Ecnoglutide Tablet formulation, as stated in the trial title.
No results, outcomes, or efficacy data have been posted for this study at this time. The information available reflects only the trial's registration status, phase, and title as listed on the registry. Readers should note that a not yet recruiting status means participant enrollment has not yet begun.
Further updates to this trial's status, including recruitment progress and any eventual results, would be expected to appear in future registry updates. For additional background on this compound, readers can consult the glucagon compound overview.